Company intelligence / Profile preview

Vertex Ventures HC

San Francisco, California, United Statesvertexventureshc.com ↗

Ownership: Private
Development stage: Other

Overview

Vertex Ventures HC manages over $400–500 million and has invested in more than two dozen healthcare/life sciences startups globally. Its focus includes biopharma therapeutics for cancer and immune disease as well as medical devices and digital health. The fund has supported at least three FDA-cleared products through its investments and currently counts about thirty clinical-stage assets within its active investment portfolio.

Therapeutic areas: OncologyImmunologyOther
Modalities: Small moleculeMonoclonal antibodyCell therapyGene therapyMedical device
Industry: Investors

Partnerships

M34 CapitalSeaX Ventures

Beyond the preview

Go deeper on Vertex Ventures HC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vertex Ventures HC.

Explore the full profile